Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
about
Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder CancerObesity and cancer progression: is there a role of fatty acid metabolism?Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique.Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray.Distinct microRNA alterations characterize high- and low-grade bladder cancerUrothelial carcinoma: stem cells on the edge.Expression profiling for bladder cancer: strategies to uncover prognostic factors.Epigenetic inactivation of ST6GAL1 in human bladder cancer.Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancerThree differentiation states risk-stratify bladder cancer into distinct subtypesPrognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitroMolecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.Tissue microarray studies in bladder cancer.Gene signatures for risk-adapted treatment of bladder cancer.High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer.The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.[Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma.
P2860
Q27310019-B9A782E3-AC3D-4AF5-B3AC-7830E04BAF97Q28081152-EBB3BB29-1901-4E10-ADDE-6252460F74C9Q33231796-1C553AF7-49FE-4D66-A306-F14D6CFF6CF8Q33317632-DFA054B4-57AF-4A8F-ADF1-D411917D2062Q33349898-520E05CD-B8E3-4A04-95FC-DC0D15B0B325Q33353831-76813790-BA78-4BCF-BC06-11EEC550046CQ33798779-ED55D773-1EFF-48A5-9303-3CB0F52D4764Q33854463-FDB4ABD6-13CD-437E-9BEF-92395A5D9987Q34092411-0C8751FB-F00B-4C5B-A847-D641683847A2Q34537170-E68FE1AC-1A25-41E7-86E9-6C181F04D7F3Q34695132-08EB485B-8DAE-4452-9163-6127B0E5DAA2Q35119480-39CB7102-9767-4A15-8229-9573EB58F6DDQ35750975-4A444B7A-5423-4769-8FBB-B1DC9CFC527FQ35770092-77A0A55F-6D26-4060-A1F3-B12BEE05A81CQ36150015-5B198577-C388-44D9-BF86-D4C2B2F5C317Q36205304-17195537-A3AF-4104-B1C6-B58C7520D902Q36215429-CB0B76FB-A3E8-4624-A9D3-0B2B836D16F6Q36341182-870375CC-4E4A-405A-A63F-23F5D7E3865EQ36691710-9986D46C-58D5-4B07-ABCC-827C92F03A25Q37278995-B1A8989C-97ED-43C8-A1F1-C7F707FB46E9Q37279004-832AB6BF-836F-4CFB-8D94-0BC23E4F0447Q37453816-412F7FE3-EDC5-4676-B06B-9228DF26A0ABQ37672390-2912867F-73AD-42C9-9C20-6DAE7252F136Q38582323-80861304-DB08-4292-B567-CA499B8F0700Q40025080-F2C60826-4C58-4A6D-AD7C-7CFAF76A521AQ44224952-302CCF0D-3D75-4873-9F6A-8780ADCE99BCQ53031106-B78D673F-BC8C-4643-A4A0-FE772806484FQ55316491-6D1511F1-ED7A-4932-B7BA-D88FB031CCDA
P2860
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gene expression profiling of p ...... inomas of the urinary bladder.
@ast
Gene expression profiling of p ...... inomas of the urinary bladder.
@en
type
label
Gene expression profiling of p ...... inomas of the urinary bladder.
@ast
Gene expression profiling of p ...... inomas of the urinary bladder.
@en
prefLabel
Gene expression profiling of p ...... inomas of the urinary bladder.
@ast
Gene expression profiling of p ...... inomas of the urinary bladder.
@en
P2093
P50
P1476
Gene expression profiling of p ...... inomas of the urinary bladder.
@en
P2093
Alexander Herr
Andre Rosenthal
Arndt Hartmann
Christoph Wissmann
Peter J Wild
Robert Stoehr
P304
P356
10.1158/1078-0432.CCR-05-0259
P407
P577
2005-06-01T00:00:00Z